Peer Insights

Get clinical insight from an allergist and an ear, nose, and throat specialist (ENT) about their experiences with XHANCE. Dr. Ow and Dr. Murphy are paid consultants of Optinose.

Watch their videos below or scroll to read about their experiences.

ENT Randall Alexander Ow, MD

ENT Randall Alexander Ow, MD
Head and Neck Surgery
Sacramento Ear, Nose and Throat Surgical and Medical Group, Inc.

Allergist Thomas R. Murphy, MD

Allergist Thomas R. Murphy, MD
Charleston ENT & Allergy

In clinical trials, XHANCE significantly improved nasal congestion at Week 4 and significantly reduced bilateral polyp grade at Week 16 (coprimary endpoints)1:

  • Average reduction in congestion using a 0-3 point scale: 0.62 XHANCE 372 mcg BID vs 0.24 placebo EDS (P<0.001)
  • Average reduction of polyp grade in a clinical trial using a 0-3 point scale: 1.41 XHANCE 372 mcg BID vs 0.61 placebo EDS (P<0.001)
The clinical trials for XHANCE evaluated over 1500 patients.2
View endoscopy videos taken before and after treatment with XHANCE.